Detalhe da pesquisa
1.
Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
Lancet Oncol
; 25(2): 198-211, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38301689
2.
Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment.
Cancer Immunol Immunother
; 72(3): 543-560, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35962843
3.
TGF-ß orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer.
Cancer Immunol Immunother
; 71(7): 1583-1596, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34727230
4.
Triple negative breast cancer-derived small extracellular vesicles as modulator of biomechanics in target cells.
Nanomedicine
; 44: 102582, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35817390
5.
Engineering amino acid uptake or catabolism promotes CAR T-cell adaption to the tumor environment.
Blood Adv
; 7(9): 1754-1761, 2023 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36521029
6.
Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets.
J Pathol Clin Res
; 9(6): 449-463, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37697694
7.
Targeting Amino Acid Metabolic Vulnerabilities in Myeloid Malignancies.
Front Oncol
; 11: 674720, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34094976
8.
Macrophage-Derived IL1ß and TNFα Regulate Arginine Metabolism in Neuroblastoma.
Cancer Res
; 79(3): 611-624, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30545920
9.
TrkAIII signals endoplasmic reticulum stress to the mitochondria in neuroblastoma cells, resulting in glycolytic metabolic adaptation.
Oncotarget
; 9(9): 8368-8390, 2018 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29492201
10.
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII.
J Exp Clin Cancer Res
; 37(1): 119, 2018 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29914559
11.
TRAIL induces pro-apoptotic crosstalk between the TRAIL-receptor signaling pathway and TrkAIII in SH-SY5Y cells, unveiling a potential therapeutic "Achilles heel" for the TrkAIII oncoprotein in neuroblastoma.
Oncotarget
; 7(49): 80820-80841, 2016 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27821809
12.
Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity.
Oncotarget
; 6(34): 35636-51, 2015 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26415233